ICER: Mer­ck­'s Covid-19 pill does­n't show 'net health ben­e­fit' but price is rea­son­able

The In­sti­tute for Clin­i­cal and Eco­nom­ic Re­view, a phar­ma drug pric­ing watch­dog, re­cent­ly dug in­to the da­ta on three Covid-19 ther­a­peu­tics, vot­ing 11-2 that there …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER